Excited to share our preprint of @ColumbiaNeuro's Phase 1b Trial of Chronic Convection Enhanced Delivery of Topotecan for Recurrent #GBM. Patients had an implantable/refillable pump-catheter system that delivered high doses of drug to core & infiltrative margin of tumor.
1/3
The New Human Tissue Immunity and Disease Initiative, to be launched later this month in @Columbia_MI, will be directed by @DonnaFarber3, the George Humphreys II Professor of Surgical Sciences and Professor of Microbiology & Immunology @Columbia_MI
https://t.co/HjueYhmnnF
Congratulations to our Associate Chair for research Dr Swanson and her team for being leaders in unraveling biases related to sex differences in the biology of brain tumors.
Fantastic work Ben and team
Subcellular proteomics of dopamine neurons in the mouse brain reveals axonal enrichment of proteins encoded by Parkinson’s disease-linked genes https://t.co/7FdQCJcdJj
Excited to have our project on sex differences in Brd4-bound enhancers in #GBM published in @PNASNews!
This was a tremendous group effort #teamscience Congratulations to everyone involved including @NKBeaumontLab, Zongtai Qi, Jeremy Rich lab, Rob Mitra lab
https://t.co/jDTwo92AsF
Our new study showing how seizures spread in the setting of #glioma. Thanks to the whole team at the Bartoli Brain Tumor Lab, as well as @NREF and @AES for funding the work.
https://t.co/DX3Va3R5r1
More awesome #gliomaNS work out of the Canoll lab this week.
Here they show how tumor induced #seizures in #glioma, lead to peritumoral hypoxia.
https://t.co/ast6n21hot